A three-state receptor model of agonist action
- PMID: 9357320
- DOI: 10.1016/s0165-6147(97)01105-x
A three-state receptor model of agonist action
Abstract
The concept that receptors can exist in multiple conformational states is becoming a physical reality. A fundamental question is how many active states need to be proposed in order to account for pharmacological observations, in particular, the finding that the same receptor type can exhibit a different agonist pharmacology when coupled to different effector pathways. In this article, Paul Leff, Clare Scaramellini, Clare Law and Ken McKechnie propose and develop a three-state receptor model in which two active conformations are assumed to exist. They show that this relatively simple theoretical model provides a basis for predicting variable agonist and inverse agonist behaviour in different systems containing the same receptor, and that it is able to account for emerging data obtained on promiscuously coupled receptors. It is argued that, while these new theoretical considerations challenge the fundamental assumptions and concepts of traditional receptor theory, the general principles of pharmacological receptor classification are largely preserved.
Similar articles
-
The two-state model of agonist action: challenges to pharmacological receptor theory.Proc West Pharmacol Soc. 1996;39:67-8. Proc West Pharmacol Soc. 1996. PMID: 8895972 Review. No abstract available.
-
Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity.Trends Pharmacol Sci. 1995 Jun;16(6):188-92. doi: 10.1016/s0165-6147(00)89020-3. Trends Pharmacol Sci. 1995. PMID: 7652927 Review.
-
A simplified empirical approach to evaluate the dissociation constant of a full agonist by the irreversible receptor inactivation method.J Pharmacol Toxicol Methods. 1998 Jul;40(1):57-62. doi: 10.1016/s1056-8719(98)00039-2. J Pharmacol Toxicol Methods. 1998. PMID: 9920535
-
A three-state receptor model: predictions of multiple agonist pharmacology for the same receptor type.Ann N Y Acad Sci. 1998 Dec 15;861:97-103. doi: 10.1111/j.1749-6632.1998.tb10179.x. Ann N Y Acad Sci. 1998. PMID: 9928245
-
Operational models of pharmacological agonism.Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141-62. doi: 10.1098/rspb.1983.0093. Proc R Soc Lond B Biol Sci. 1983. PMID: 6141562
Cited by
-
Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.Br J Clin Pharmacol. 2004 Apr;57(4):373-87. doi: 10.1111/j.1365-2125.2003.02046.x. Br J Clin Pharmacol. 2004. PMID: 15025734 Free PMC article. Review.
-
Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development.Pharmacol Res. 2017 Nov;125(Pt B):161-177. doi: 10.1016/j.phrs.2017.08.008. Epub 2017 Aug 23. Pharmacol Res. 2017. PMID: 28838808 Free PMC article.
-
Both ligand- and cell-specific parameters control ligand agonism in a kinetic model of g protein-coupled receptor signaling.PLoS Comput Biol. 2007 Jan 12;3(1):e6. doi: 10.1371/journal.pcbi.0030006. PLoS Comput Biol. 2007. PMID: 17222056 Free PMC article.
-
Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors.Mol Pharmacol. 2009 Feb;75(2):381-96. doi: 10.1124/mol.108.051276. Epub 2008 Nov 7. Mol Pharmacol. 2009. PMID: 18996972 Free PMC article.
-
Inverse agonist and pharmacochaperone properties of MK-0524 on the prostanoid DP1 receptor.PLoS One. 2013 Jun 10;8(6):e65767. doi: 10.1371/journal.pone.0065767. Print 2013. PLoS One. 2013. PMID: 23762421 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
